COMT and Parkinson disease: In 1997, Tolcapone was the first COMT inhibitor to be approved for PD with motor fluctuations, after demonstrating significant reduction of OFF time in randomized placebo-controlled studies (Baas et al. 1997; Kurth et al. 1997; Adler et al. 1998; Rajput et al. 1998).